Holistic management of juvenile idiopathic arthritis across all ages: British Society for Rheumatology Guideline scope

Compeyrot-Lacassagne, S ORCID: 0000-0001-5533-7493, Beesley, RP, Bray, L ORCID: 0009-0009-1527-6011, Bridges, A, Chaplin, H, Ciurtin, C ORCID: 0000-0002-8911-4113, Cleary, G, Cooray, S ORCID: 0000-0001-6103-8895, Aragon Cuevas, O, Cuthbert, V, Deepak, S, Earle, E, Ferreira, A, Kearsley-Fleet, L ORCID: 0000-0003-0377-1575, Gupta, J, Houston, R, Hum, RM ORCID: 0000-0003-0801-6974, Humphreys, JH, Jayasekera, HS, Jones, S et al (2026) Holistic management of juvenile idiopathic arthritis across all ages: British Society for Rheumatology Guideline scope. Rheumatology Advances in Practice, 10 (2). pp. 1-11. ISSN 2514-1775

Preview

Text Holistic management of juvenile idiopathic arthritis across all ages.pdf - Published Version Available under License Creative Commons Attribution. Download (710kB) | Preview

Abstract

Lay Summary: What does this mean for patients? Juvenile idiopathic arthritis (JIA) is the most common type of arthritis that starts before the age of 16 years. Many children and young people (CYP) continue to be affected by JIA and may need to be on treatment when they are adults. Most CYP with JIA have swollen, stiff and painful joints for at least 6 weeks. JIA can also affect other parts of the body. This includes the skin, the places where tendons join bones (called entheses) and sometimes internal organs. Some young people may also develop inflammation in their eyes, called uveitis. If this is not treated, it can affect eyesight and could lead to sight loss. People with JIA often need medicines to control inflammation. They are usually cared for by a team of healthcare professionals called a multidisciplinary team. This team may include doctors, nurses, pharmacists, physiotherapists, occupational therapists, podiatrists, psychologists and youth workers. They work together to help manage symptoms and prevent long-term damage. The British Society for Rheumatology (BSR) is the main organisation in the UK for healthcare professionals who care for people with JIA. BSR writes guidelines that help healthcare teams provide high-quality care. These guidelines are written with input from experts and people with lived experience. They help make sure that everyone receives good care wherever they live, including during the move from child to adult services. This article explains how BSR will develop a new guideline to diagnose, treat and monitor children, young people and adults with JIA. The guideline will follow the BSR protocol for creating clinical guidelines.

Item Type:	Article
Uncontrolled Keywords:	British Society for Rheumatology Guideline Steering Group ; Guideline scope; Holistic management; Juvenile Idiopathic Arthritis; Life course; 32 Biomedical and Clinical Sciences; 3202 Clinical Sciences; Health Services; Autoimmune Disease; Pediatric Research Initiative; Rare Diseases; Women's Health; Arthritis; Clinical Research; Rheumatoid Arthritis; 7.3 Management and decision making; Inflammatory and immune system; 3 Good Health and Well Being; 3202 Clinical sciences
Subjects:	R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica
Divisions:	Pharmacy and Biomolecular Sciences
Publisher:	Oxford University Press
Date of acceptance:	19 April 2026
Date of first compliant Open Access:	26 October 2026
Date Deposited:	26 Oct 2026 11:55
Last Modified:	26 Oct 2026 11:55
DOI or ID number:	10.1093/rap/rkag052
URI:	https://researchonline.ljmu.ac.uk/id/eprint/29742

View Item